GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adynxx Inc (STU:HL1B) » Definitions » Liabilities-to-Assets

Adynxx (STU:HL1B) Liabilities-to-Assets : 4.40 (As of Sep. 2019)


View and export this data going back to 1998. Start your Free Trial

What is Adynxx Liabilities-to-Assets?

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Adynxx's Total Liabilities for the quarter that ended in Sep. 2019 was €13.00 Mil. Adynxx's Total Assets for the quarter that ended in Sep. 2019 was €2.96 Mil. Therefore, Adynxx's Liabilities-to-Assets Ratio for the quarter that ended in Sep. 2019 was 4.40.


Adynxx Liabilities-to-Assets Historical Data

The historical data trend for Adynxx's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adynxx Liabilities-to-Assets Chart

Adynxx Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Liabilities-to-Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.24 0.42 0.41 0.52 0.15

Adynxx Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Liabilities-to-Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.25 0.15 0.27 4.42 4.40

Competitive Comparison of Adynxx's Liabilities-to-Assets

For the Biotechnology subindustry, Adynxx's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adynxx's Liabilities-to-Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Adynxx's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Adynxx's Liabilities-to-Assets falls into.



Adynxx Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Adynxx's Liabilities-to-Assets Ratio for the fiscal year that ended in Dec. 2018 is calculated as:

Liabilities-to-Assets (A: Dec. 2018 )=Total Liabilities/Total Assets
=1.254/8.508
=0.15

Adynxx's Liabilities-to-Assets Ratio for the quarter that ended in Sep. 2019 is calculated as

Liabilities-to-Assets (Q: Sep. 2019 )=Total Liabilities/Total Assets
=12.999/2.955
=4.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Adynxx  (STU:HL1B) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.


Adynxx Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Adynxx's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Adynxx (STU:HL1B) Business Description

Traded in Other Exchanges
N/A
Address
100 Pine Street, Suite 500, San Francisco, CA, USA, 94111
Adynxx Inc is a United States-based clinical-stage biopharmaceutical company. It is focused on the development of a new class of therapeutics called transcription factor decoys and bringing to the market novel, disease-modifying products to address unmet needs in the treatment of pain and inflammation. Its pipeline includes brivoligide, a Phase 2 drug candidate intended to address postoperative pain, and AYX2, a pre-clinical candidate intended to treat chronic syndromes of pain, including both inflammatory and neuropathic pain.

Adynxx (STU:HL1B) Headlines

No Headlines